Anika Therapeutics ( NASDAQ:ANIK ) First Quarter 2024 Results Key Financial Results Revenue: US$40.5m (up 6.9% from 1Q...
Anika Therapeutics, Inc. (NASDAQ:ANIK) Q1 2024 Earnings Call Transcript May 8, 2024 Anika Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.30712 EPS, expectations were $-0.19. Anika Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good evening, […]
Q1 2024 Anika Therapeutics Inc Earnings Call